IMCD N.V. (0QVU.L)
| Previous close | 146.98 |
| Open | 146.20 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 145.85 - 146.20 |
| 52-week range | 107.85 - 156.50 |
| Volume | |
| Avg. volume | 53,040 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Is It Too Late To Consider Buying IMCD N.V. (AMS:IMCD)?
IMCD N.V. ( AMS:IMCD ), might not be a large cap stock, but it received a lot of attention from a substantial price...
GlobeNewswireIMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L. (“Selechimica”), an Italian distributor in the pharmaceutical industry. Headquartered in Milan, Italy, Selechimica distributes an extensive portfolio of Active Pharmaceutical Ingredients (APIs). With 3 employees, Selechimica represe
Business WireNu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC Regions
MINNETONKA, Minn., June 04, 2024--Nu-Tek has executed an agreement with IMCD for distribution of its peptones and hydrolysates into Europe & Asia Pacific.
